Statements (105)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:species
|
gptkbp:affects |
gptkb:Dog
gptkb:animals gptkb:humans cats |
gptkbp:associated_with |
rural areas
poverty gastrointestinal complications cardiac complications |
gptkbp:belongs_to |
gptkb:Trypanosomatidae
|
gptkbp:cause |
Chagas disease
|
gptkbp:class |
gptkb:Kinetoplastida
|
gptkbp:communication_system |
gptkb:Triatomine_bugs
|
gptkbp:community_health |
significant in endemic areas
|
gptkbp:diagnosis |
PCR
serological tests |
gptkbp:discovered_by |
gptkb:Carlos_Chagas
|
gptkbp:discovery_year |
1909
|
gptkbp:diseases |
gptkb:Brain
organ transplantation blood transfusion smooth muscle cells heart muscle cells congenital transmission |
gptkbp:endemic_to |
gptkb:Latin_America
|
gptkbp:family |
gptkb:Trypanosomatidae
|
gptkbp:first_isolation |
in 1909
|
gptkbp:genus |
gptkb:Trypanosoma
|
gptkbp:geographic_distribution |
endemic regions
|
gptkbp:has_features |
flagellated protozoan
|
https://www.w3.org/2000/01/rdf-schema#label |
Trypanosoma cruzi
|
gptkbp:is_a |
gptkb:Parasite
species of Trypanosoma |
gptkbp:is_associated_with |
rural areas
poverty poor housing conditions |
gptkbp:is_examined_in |
molecular biology
environmental factors clinical trials socioeconomic factors treatment efficacy genomic studies control strategies epidemiological trends host-parasite interactions diagnostic methods public health impact treatment resistance transmission dynamics vector ecology |
gptkbp:is_found_in |
gptkb:Central_America
gptkb:Mexico gptkb:South_America |
gptkbp:is_involved_in |
immune response
|
gptkbp:is_linked_to |
gptkb:Cardiology
gastrointestinal complications |
gptkbp:is_monitored_by |
public health organizations
epidemiological studies |
gptkbp:is_part_of |
zoonotic diseases
Trypanosoma genus Chagas disease complex |
gptkbp:is_related_to |
gptkb:American_trypanosomiasis
vector control efforts |
gptkbp:is_studied_for |
genetic diversity
vaccine development pathogenesis |
gptkbp:is_studied_in |
parasitology
|
gptkbp:is_vector_borne |
yes
|
gptkbp:is_vulnerable_to |
insecticides
some treatments |
gptkbp:life_cycle |
amastigote
epimastigote trypomastigote heteroxenous |
gptkbp:order |
gptkb:Kinetoplastida
|
gptkbp:phylum |
gptkb:Euglenozoa
|
gptkbp:prevalence |
affects millions of people
endemic in Latin America |
gptkbp:prevention |
public health education
vector control measures screening blood donations |
gptkbp:research_focus |
vector control
vaccine development treatment development |
gptkbp:research_institutes |
various universities and health organizations
|
gptkbp:scientific_classification |
neglected tropical disease
|
gptkbp:seed_dispersal |
approximately 100 million base pairs
|
gptkbp:species |
gptkb:Trypanosoma
|
gptkbp:subgenres |
gptkb:Kinetoplastea
|
gptkbp:symptoms |
fatigue
fever swelling digestive issues acute phase symptoms chronic phase symptoms heart complications |
gptkbp:treatment |
gptkb:benznidazole
nifurtimox |
gptkbp:type |
gptkb:Parasite
|
gptkbp:vector |
gptkb:Panstrongylus_megistus
gptkb:Rhodnius_prolixus gptkb:Triatoma_infestans |
gptkbp:wildlife |
yes
|
gptkbp:bfsParent |
gptkb:Trypanosoma
|
gptkbp:bfsLayer |
5
|